| Literature DB >> 33162617 |
Mohamed Abdel-Basset1, Victor Chang2, Nada A Nabeeh3.
Abstract
This paper describes a framework using disruptive technologies for COVID-19 analysis. Disruptive technologies include high-tech and emerging technologies such as AI, industry 4.0, IoT, Internet of Medical Things (IoMT), big data, virtual reality (VR), Drone technology, and Autonomous Robots, 5 G, and blockchain to offer digital transformation, research and development and service delivery. Disruptive technologies are essential for Industry 4.0 development, which can be applied to many disciplines. In this paper, we present a framework that uses disruptive technologies for COVID-19 analysis. The proposed framework restricts the spread of COVID-19 outbreaks, ensures the safety of the healthcare teams and maintains patients' physical and psychological healthcare conditions. The framework is designed to deal with the severe shortage of PPE for the medical team, reduce the massive pressure on hospitals, and track recovered patients to treat COVID-19 patients with plasma. The study provides oversight for governments on how to adopt technologies to reduce the impact of unprecedented outbreaks for COVID-19. Our work illustrates an empirical case study on the analysis of real COVID-19 patients and shows the importance of the proposed intelligent framework to limit the current outbreaks for COVID-19. The aim is to help the healthcare team make rapid decisions to treat COVID-19 patients in hospitals, home quarantine, or identifying and treating patients with typical cold or flu.Entities:
Keywords: 5 G; Blockchain; Covid-19; Healthcare; Industry 4.0; Internet of medical things (iomt)
Year: 2020 PMID: 33162617 PMCID: PMC7598374 DOI: 10.1016/j.techfore.2020.120431
Source DB: PubMed Journal: Technol Forecast Soc Change ISSN: 0040-1625
The disruptive technologies used to limit the COVID-19 outbreaks.
| AI is a powerful tool and technique that makes computers to learn and think. AI can make predictions of patterns. | The AI can be used to predict the outbreak for COVID-19. The AI has analysis models to test the validity of the statistical data about COVID-19, consequently remove unwanted data. The AI develops robots to burden from the healthcare team some duties to perform the medical examination of patients. | |
| Industry 4.0 augments industry advancements based on the focus on environmental conditions and the development of related technologies ( | Industry 4.0 developed many applications for the sake of solving healthcare problems. Industry 4.0 can analyze the patients' real data with various technological methods to increase the accuracy of the rapid and accurate diagnosis and treatment (Javaid et al., 2019). | |
| The connection between objects over a specific network without human intervene. People could access the needed content remotely from anywhere to attain the proper medical service ( | IoT is a useful technology to prevent COVID-19 outbreaks. The sensors can make a periodic follow up for hospitalized patients or home quarantine patients ( | |
| IoMT is a contemporary mean for connecting the medical sensor devices and the associated applications with healthcare technology systems via networks connectivity ( | The IoMT takes the medical team's burden to perform data sharing, monitor patient reports, track patients and contact, gather vital signs, etc. ( | |
| Big data is a discipline that analyzes and extracts information and features from large and complex data that cannot be traditionally processed with application software. | The big data can make a practical analysis of the data generated from sensors and healthcare databases to produce many statistics about the COVID-19 outbreaks and other reports to limit the effect of pandemic across the world ( | |
| VR is a technology used in a computer program to create a suitable simulated environment. People can participate in work in real-time through a distributed whiteboard. | VR offers an appropriate environment for a video call between the healthcare team with patients in hospitals or in-home quarantine. The VR can improve patients' psychological side, especially the home quarantine patients, to make them feel that the healthcare team follows up on all the vital signs and any consequence complications of COVID-19 ( | |
| Drone technology is a flying robot controlled by a software application. Like drone technology, the autonomous robot has the capability to carry out specific responsibilities without the intervention of external agencies ( | Drone technology can be used to reach specific areas in the infected country and minimize human interaction ( | |
| The fifth-generation technology can support global mobile networks (Qualcomm et al., 2020). The 5 G provides more excellent characteristics than 3 G and 4 G. | The 5 G can cooperate with the pandemic of COVID-19 by providing the healthcare team rapid speed communication between assistance to improve the track of COVID-19 and continuously monitoring and analyzing the patients' cases. | |
| Blockchain is a transaction record between two parties (Alladia et al., 2019 a). | The blockchain can be used to limit the pandemic of COVID—19 by making the integration of different data sources (Alladi et al., 2019 b) |
The presentation for symptoms of COVID-19.
| Fever | 83%-99% |
| Dry Cough | 59%-82% |
| Fatigue | 44%-70% |
| Anorexia | 40%-84% |
| Shortness of breath | 31%-40% |
| Sputum production | 28%-33% |
| Myalgias | 11%-35% |
| Headache, confusion, rhinorrhea, sore throat, hemoptysis, vomiting, and diarrhea | <10% |
| Loss of smell (anosmia) | Variable/undetermined |
| Loss of taste (ageusia) | Variable/undetermined |
Fig. 5The general intelligent framework proposed to limit the pandemic of COVID-19.
Fig. 6Procedures for the proposed intelligent framework to limit the COVID-19 outbreaks.
Fig. 7The proposed intelligent framework treatment using IoT technologies.
Fig. 8The proposed intelligent framework treatment using IoMT technologies.
Fig. 2The workflow for the main categories affected COVID-19 patients.
The data type for differentiation of COVID-19 patients' categories.
| Fever | Cough | |
| Respiratory rate | Dyspnea | |
| Oxygen saturation | Mechanical Ventilations |
Fig. 9The chest X-ray for mild COVID-19 patients.
Fig. 10The chest X-ray for moderate COVID-19 patients.
Fig. 11The chest X-ray for severe COVID-19 patients.
Fig. 12The chest X-ray for critical COVID-19 patients.
Definitions for different COVID-19 patient's categories according to clinical parameters.
| Mild | × | × (Respiratory rate<22 breath per min) | No evidence of pneumonia | >94% | × | ||
| Moderate | (Respiratory rate<30 breath per min) | Evidence of pneumonia (not severe) | 90%-94% | × | |||
| Severe | (Respiratory rate> 30 breath per min | Evidence of severe pneumonia. | < 90% | × | |||
| Critical | (Respiratory rate> 30 breath per min | Bilateral opacities, lung collapse, may occur | <85% |
Clinical parameters for samples of COVID-19 patients.
| 1 | 38.1 | 1 | 0 | 27 | 0 | 92% | 0 | Moderate |
| 2 | 37.7 | 1 | 0 | 20 | 0 | 97% | 0 | Mild |
| 3 | 38 | 1 | 1 | 29 | 1 | 93% | 0 | Moderate |
| 4 | 39.2 | 1 | 1 | 39 | 3 | 81% | 1 | Critical |
| 5 | 37.5 | 1 | 0 | 19 | 0 | 99% | 0 | Mild |
| 6 | 38.9 | 1 | 1 | 34 | 2 | 89% | 0 | Severe |
| 7 | 39.4 | 1 | 1 | 41 | 3 | 78% | 1 | Critical |
| 8 | 38.2 | 1 | 1 | 29 | 1 | 94% | 0 | Moderate |
| 9 | 39 | 1 | 1 | 36 | 2 | 88% | 0 | Severe |
| 10 | 37.7 | 1 | 0 | 22 | 0 | 97% | 0 | Mild |
| 11 | 39.2 | 1 | 1 | 32 | 2 | 90% | 0 | Severe |
| 12 | 38.4 | 1 | 1 | 28 | 1 | 93% | 0 | Moderate |
| 13 | 39.7 | 1 | 1 | 37 | 3 | 83% | 1 | Critical |
| 14 | 37.6 | 1 | 0 | 18 | 0 | 99% | 0 | Mild |
| 15 | 39 | 1 | 1 | 31 | 2 | 87% | 0 | Severe |
| 16 | 38.3 | 1 | 1 | 24 | 1 | 94% | 0 | Moderate |
| 17 | 39.5 | 1 | 1 | 37 | 3 | 80% | 1 | Critical |
| 18 | 39.8 | 1 | 1 | 41 | 3 | 79% | 1 | Critical |
| 19 | 37.6 | 1 | 0 | 21 | 0 | 98% | 0 | Mild |
| 20 | 38.4 | 1 | 1 | 32 | 2 | 89% | 0 | Severe |
Fig. 13The traditional procedures for the use of monitor in hospitals.
The criterions considered in discussion and results.
| Dry Cough | |
| Fever | |
| Fatigue | |
| Shortness of breath | |
| Anorexia | |
| Sputum production | |
| Headache | |
| Myalgias | |
| Confusion | |
| Rhinorrhea | |
| Sore throat | |
| Vomiting | |
| Diarrhea | |
| Hemoptysis | |
| Loss of smell (anosmia) | |
| Loss of taste (ageusia) |
Fig. 14The future trends of research in the light of the proposed intelligent framework.